ACTAVIS LABS FL INC FDA Approval ANDA 203693

ANDA 203693

ACTAVIS LABS FL INC

FDA Drug Application

Application #203693

Application Sponsors

ANDA 203693ACTAVIS LABS FL INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001TABLET;SUBLINGUAL0.3MG0NITROGLYCERINNITROGLYCERIN
002TABLET;SUBLINGUAL0.4MG0NITROGLYCERINNITROGLYCERIN
003TABLET;SUBLINGUAL0.6MG0NITROGLYCERINNITROGLYCERIN

FDA Submissions

UNKNOWN; ORIG1AP2017-10-16

Submissions Property Types

ORIG1Null7

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203693
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NITROGLYCERIN","activeIngredients":"NITROGLYCERIN","strength":"0.3MG","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NITROGLYCERIN","activeIngredients":"NITROGLYCERIN","strength":"0.4MG","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NITROGLYCERIN","activeIngredients":"NITROGLYCERIN","strength":"0.6MG","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/16\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-10-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.